Cost-effectiveness of using a social franchise network to increase uptake of oral rehydration salts and zinc for childhood diarrhea in rural Myanmar

• Published in: Cost effectiveness and resource allocation Vol. 13; no. 1; p. 3
• Main Authors: Bishai, David, Sachathep, Karampreet, LeFevre, Amnesty, Thant, Hnin New Nwe, Zaw, Min, Aung, Tin, McFarland, Willi, Montagu, Dominic
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.02.2015; BioMed Central
• Subjects: Care and treatment; Comparative analysis; Diarrhea in children; Economic aspects; Franchising; Health aspects; Households; Monte Carlo method; Parenting; Political aspects; Risk factors; Social aspects; Zinc in the body; Zinc products; Myanmar; Myanmar; Costing; Social franchise; Cluster randomized trial; Private providers; Burma; Zinc; Oral rehydration
• ISSN: 1478-7547; 1478-7547
• DOI: 10.1186/s12962-015-0030-3

This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social franchising. The study uses cost and outcome data from an initiative by Population Services International (PSI) in 3 townships of Myanmar in 2010 to promote an ORS-Zinc product called ORASEL. The objective of this study was to determine the incremental cost-effectiveness of a strategy to promote ORS-Z use through private sector franchising compared to standard government and private sector practices. Costing from a societal perspective included program, provider, and household costs for the 2010 calendar year. Program costs including ORASEL program launch, distribution, and administration costs were obtained through a retrospective review of financial records and key informant interviews with staff in the central Yangon office. Household out of pocket payments for diarrheal episodes were obtained from a household survey conducted in the study area and additional estimates of household income lost due to parental care-giving time for a sick child were estimated. Incremental cost-effectiveness relative to status quo conditions was calculated per child death and DALY averted in 2010. Health effects included deaths and DALYs averted; the former modeled based on coverage estimates from a household survey that were entered into the Lives Saved Tool (LiST). Uncertainty was modeled with Monte Carlo methods. Based on the model, the promotional strategy would translate to 2.85 (SD 0.29) deaths averted in a community population of 1 million where there would be 81,000 children under 5 expecting 48,373 cases of diarrhea. The incremental cost effectiveness of the franchised approach to improving ORASEL coverage is estimated at a median $5,955 (IQR: $3437-$7589) per death averted and $214 (IQR: $127-$287) per discounted DALY averted. Investing in developing a network of private sector providers and keeping them stocked with ORS-Z as is done in a social franchise can be a highly cost-effective in terms of dollars per DALY averted.